|
| Phase III Services |
Biomedical Consulting International, Inc has extensive experience in
the development of product development strategies to enable new chemical/biological
entities and/or new dosage forms of existing entities and/or new/improved
medical devices to move from Phase II to Phase III clinical trials
as expeditiously as possible. BCI Phase III Clinical Services may take
many forms:
- From strategic oversight;
- To partnering with the client to develop the pivotal clinical trial
design and the rest of the support package; this may also include
the preparation for and attendance at meetings with regulatory
authorities associated development program such as the End of Phase
II meeting with FDA;
- To BCI performing all services required on behalf of the client
to enable the entry into Phase III.
|
|
|
